22 November 2017
News and Views
Links and Services
A study in December's issue of the Alimentary Pharmacology & Therapeutics investigates the association between psoriasis and anti-tumor necrosis factor therapy in IBD.
Anti-tumor necrosis factor (TNF) antibodies are used to treat both psoriasis and inflammatory bow
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors